News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Transgene lance une levée de fonds d’un montant d’environ 105 millions d’euros
-
COMMUNIQUÉ DE PRESSE
Transgene launches a fundraising campaign for approximately 105 million euros
Transgene launches a fundraising of approximately 105 million euros through new share issuance to investors. Funding to advance myvac program for personalized cancer vaccines and ensure financial stability until early 2028 -
-
-
COMMUNIQUÉ DE PRESSE
Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines
Transgene to present VacDesignR® tool at ESMO-AI 2025 for optimized cancer vaccine design. Tool enhances virus efficiency and yield for individualized therapies
